A citation-based method for searching scientific literature

Vaibhav Kumar, Joshua T Cohen, David van Klaveren, Djøra I Soeteman, John B Wong, Peter J Neumann, David M Kent. Ann Intern Med 2018
Times Cited: 59







List of co-cited articles
524 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Reduced lung-cancer mortality with low-dose computed tomographic screening.
Denise R Aberle, Amanda M Adams, Christine D Berg, William C Black, Jonathan D Clapp, Richard M Fagerstrom, Ilana F Gareen, Constantine Gatsonis, Pamela M Marcus, JoRean D Sicks. N Engl J Med 2011
76


Selection criteria for lung-cancer screening.
Martin C Tammemägi, Hormuzd A Katki, William G Hocking, Timothy R Church, Neil Caporaso, Paul A Kvale, Anil K Chaturvedi, Gerard A Silvestri, Tom L Riley, John Commins,[...]. N Engl J Med 2013
536
44

Cost-effectiveness of CT screening in the National Lung Screening Trial.
William C Black, Ilana F Gareen, Samir S Soneji, JoRean D Sicks, Emmett B Keeler, Denise R Aberle, Arash Naeim, Timothy R Church, Gerard A Silvestri, Jeremy Gorelick,[...]. N Engl J Med 2014
342
40

Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.
Hormuzd A Katki, Stephanie A Kovalchik, Christine D Berg, Li C Cheung, Anil K Chaturvedi. JAMA 2016
173
38

Targeting of low-dose CT screening according to the risk of lung-cancer death.
Stephanie A Kovalchik, Martin Tammemagi, Christine D Berg, Neil E Caporaso, Tom L Riley, Mary Korch, Gerard A Silvestri, Anil K Chaturvedi, Hormuzd A Katki. N Engl J Med 2013
392
38

Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial.
Harry J de Koning, Carlijn M van der Aalst, Pim A de Jong, Ernst T Scholten, Kristiaan Nackaerts, Marjolein A Heuvelmans, Jan-Willem J Lammers, Carla Weenink, Uraujh Yousaf-Khan, Nanda Horeweg,[...]. N Engl J Med 2020
958
38

Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study.
Kevin Ten Haaf, Jihyoun Jeon, Martin C Tammemägi, Summer S Han, Chung Yin Kong, Sylvia K Plevritis, Eric J Feuer, Harry J de Koning, Ewout W Steyerberg, Rafael Meza. PLoS Med 2017
152
37

Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force.
Harry J de Koning, Rafael Meza, Sylvia K Plevritis, Kevin ten Haaf, Vidit N Munshi, Jihyoun Jeon, Saadet Ayca Erdogan, Chung Yin Kong, Summer S Han, Joost van Rosmalen,[...]. Ann Intern Med 2014
327
35

Implications of Nine Risk Prediction Models for Selecting Ever-Smokers for Computed Tomography Lung Cancer Screening.
Hormuzd A Katki, Stephanie A Kovalchik, Lucia C Petito, Li C Cheung, Eric Jacobs, Ahmedin Jemal, Christine D Berg, Anil K Chaturvedi. Ann Intern Med 2018
86
33

The Cost-Effectiveness of High-Risk Lung Cancer Screening and Drivers of Program Efficiency.
Sonya Cressman, Stuart J Peacock, Martin C Tammemägi, William K Evans, Natasha B Leighl, John R Goffin, Alain Tremblay, Geoffrey Liu, Daria Manos, Paul MacEachern,[...]. J Thorac Oncol 2017
76
30

Overdiagnosis in low-dose computed tomography screening for lung cancer.
Edward F Patz, Paul Pinsky, Constantine Gatsonis, Jorean D Sicks, Barnett S Kramer, Martin C Tammemägi, Caroline Chiles, William C Black, Denise R Aberle. JAMA Intern Med 2014
501
28

Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada.
Kevin Ten Haaf, Martin C Tammemägi, Susan J Bondy, Carlijn M van der Aalst, Sumei Gu, S Elizabeth McGregor, Garth Nicholas, Harry J de Koning, Lawrence F Paszat. PLoS Med 2017
85
28

Variations in lung cancer risk among smokers.
Peter B Bach, Michael W Kattan, Mark D Thornquist, Mark G Kris, Ramsey C Tate, Matt J Barnett, Lillian J Hsieh, Colin B Begg. J Natl Cancer Inst 2003
415
25

Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment.
Paul F Pinsky, David S Gierada, William Black, Reginald Munden, Hrudaya Nath, Denise Aberle, Ella Kazerooni. Ann Intern Med 2015
287
25

The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer.
John K Field, Stephen W Duffy, David R Baldwin, Kate E Brain, Anand Devaraj, Tim Eisen, Beverley A Green, John A Holemans, Terry Kavanagh, Keith M Kerr,[...]. Health Technol Assess 2016
142
25

Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts.
Martin C Tammemägi, Timothy R Church, William G Hocking, Gerard A Silvestri, Paul A Kvale, Thomas L Riley, John Commins, Christine D Berg. PLoS Med 2014
185
23

European position statement on lung cancer screening.
Matthijs Oudkerk, Anand Devaraj, Rozemarijn Vliegenthart, Thomas Henzler, Helmut Prosch, Claus P Heussel, Gorka Bastarrika, Nicola Sverzellati, Mario Mascalchi, Stefan Delorme,[...]. Lancet Oncol 2017
300
23

Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology.
Douglas E Wood, Ella A Kazerooni, Scott L Baum, George A Eapen, David S Ettinger, Lifang Hou, David M Jackman, Donald Klippenstein, Rohit Kumar, Rudy P Lackner,[...]. J Natl Compr Canc Netw 2018
285
23

UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening.
J K Field, S W Duffy, D R Baldwin, D K Whynes, A Devaraj, K E Brain, T Eisen, J Gosney, B A Green, J A Holemans,[...]. Thorax 2016
197
23

Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.
Martin C Tammemagi, Heidi Schmidt, Simon Martel, Annette McWilliams, John R Goffin, Michael R Johnston, Garth Nicholas, Alain Tremblay, Rick Bhatia, Geoffrey Liu,[...]. Lancet Oncol 2017
117
22

Implementing lung cancer screening: baseline results from a community-based 'Lung Health Check' pilot in deprived areas of Manchester.
Phil A Crosbie, Haval Balata, Matthew Evison, Melanie Atack, Val Bayliss-Brideaux, Denis Colligan, Rebecca Duerden, Josephine Eaglesfield, Timothy Edwards, Peter Elton,[...]. Thorax 2019
103
22

Screening for Lung Cancer: CHEST Guideline and Expert Panel Report.
Peter J Mazzone, Gerard A Silvestri, Sheena Patel, Jeffrey P Kanne, Linda S Kinsinger, Renda Soylemez Wiener, Guy Soo Hoo, Frank C Detterbeck. Chest 2018
174
18

Selecting High-Risk Individuals for Lung Cancer Screening: A Prospective Evaluation of Existing Risk Models and Eligibility Criteria in the German EPIC Cohort.
Kuanrong Li, Anika Hüsing, Disorn Sookthai, Manuela Bergmann, Heiner Boeing, Nikolaus Becker, Rudolf Kaaks. Cancer Prev Res (Phila) 2015
67
18


Identifying Patients for Whom Lung Cancer Screening Is Preference-Sensitive: A Microsimulation Study.
Tanner J Caverly, Pianpian Cao, Rodney A Hayward, Rafael Meza. Ann Intern Med 2018
47
23

Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial.
Eugenio Paci, Donella Puliti, Andrea Lopes Pegna, Laura Carrozzi, Giulia Picozzi, Fabio Falaschi, Francesco Pistelli, Ferruccio Aquilini, Cristina Ocello, Marco Zappa,[...]. Thorax 2017
141
18

Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial.
Nikolaus Becker, Erna Motsch, Anke Trotter, Claus P Heussel, Hendrik Dienemann, Philipp A Schnabel, Hans-Ulrich Kauczor, Sandra González Maldonado, Anthony B Miller, Rudolf Kaaks,[...]. Int J Cancer 2020
145
18

Incorporating Coexisting Chronic Illness into Decisions about Patient Selection for Lung Cancer Screening. An Official American Thoracic Society Research Statement.
M Patricia Rivera, Nichole T Tanner, Gerard A Silvestri, Frank C Detterbeck, Martin C Tammemägi, Robert P Young, Christopher G Slatore, Tanner J Caverly, Cynthia M Boyd, Dejana Braithwaite,[...]. Am J Respir Crit Care Med 2018
45
22

Life-Gained-Based Versus Risk-Based Selection of Smokers for Lung Cancer Screening.
Li C Cheung, Christine D Berg, Philip E Castle, Hormuzd A Katki, Anil K Chaturvedi. Ann Intern Med 2019
43
23

A Comparative Modeling Analysis of Risk-Based Lung Cancer Screening Strategies.
Kevin Ten Haaf, Mehrad Bastani, Pianpian Cao, Jihyoun Jeon, Iakovos Toumazis, Summer S Han, Sylvia K Plevritis, Erik F Blom, Chung Yin Kong, Martin C Tammemägi,[...]. J Natl Cancer Inst 2020
44
22

Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy.
U Pastorino, M Silva, S Sestini, F Sabia, M Boeri, A Cantarutti, N Sverzellati, G Sozzi, G Corrao, A Marchianò. Ann Oncol 2019
135
16

Long-term psychosocial outcomes of low-dose CT screening: results of the UK Lung Cancer Screening randomised controlled trial.
Kate Brain, Kate J Lifford, Ben Carter, Olivia Burke, Fiona McRonald, Anand Devaraj, David M Hansell, David Baldwin, Stephen W Duffy, John K Field. Thorax 2016
55
18

Identifying high risk individuals for targeted lung cancer screening: Independent validation of the PLCOm2012 risk prediction tool.
Marianne Weber, Sarsha Yap, David Goldsbury, David Manners, Martin Tammemagi, Henry Marshall, Fraser Brims, Annette McWilliams, Kwun Fong, Yoon Jung Kang,[...]. Int J Cancer 2017
59
15

The LLP risk model: an individual risk prediction model for lung cancer.
A Cassidy, J P Myles, M van Tongeren, R D Page, T Liloglou, S W Duffy, J K Field. Br J Cancer 2008
293
15

Benefits and harms of CT screening for lung cancer: a systematic review.
Peter B Bach, Joshua N Mirkin, Thomas K Oliver, Christopher G Azzoli, Donald A Berry, Otis W Brawley, Tim Byers, Graham A Colditz, Michael K Gould, James R Jett,[...]. JAMA 2012
823
15

Cost-effectiveness of low-dose CT screening for lung cancer in a European country with high prevalence of smoking-A modelling study.
Yuki Tomonaga, Kevin Ten Haaf, Thomas Frauenfelder, Malcolm Kohler, Roger D Kouyos, Mohaned Shilaih, Matthias Lorez, Harry J de Koning, Matthias Schwenkglenks, Milo A Puhan. Lung Cancer 2018
30
30

Impact of low-dose CT screening on smoking cessation among high-risk participants in the UK Lung Cancer Screening Trial.
Kate Brain, Ben Carter, Kate J Lifford, Olivia Burke, Anand Devaraj, David R Baldwin, Stephen Duffy, John K Field. Thorax 2017
72
15

Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis.
Cristiano Rampinelli, Paolo De Marco, Daniela Origgi, Patrick Maisonneuve, Monica Casiraghi, Giulia Veronesi, Lorenzo Spaggiari, Massimo Bellomi. BMJ 2017
132
15

Results of initial low-dose computed tomographic screening for lung cancer.
Timothy R Church, William C Black, Denise R Aberle, Christine D Berg, Kathy L Clingan, Fenghai Duan, Richard M Fagerstrom, Ilana F Gareen, David S Gierada, Gordon C Jones,[...]. N Engl J Med 2013
675
15

Implementation of Lung Cancer Screening in the Veterans Health Administration.
Linda S Kinsinger, Charles Anderson, Jane Kim, Martha Larson, Stephanie H Chan, Heather A King, Kathryn L Rice, Christopher G Slatore, Nichole T Tanner, Kathleen Pittman,[...]. JAMA Intern Med 2017
205
13

Probability of cancer in pulmonary nodules detected on first screening CT.
Annette McWilliams, Martin C Tammemagi, John R Mayo, Heidi Roberts, Geoffrey Liu, Kam Soghrati, Kazuhiro Yasufuku, Simon Martel, Francis Laberge, Michel Gingras,[...]. N Engl J Med 2013
697
13

The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology.
Paul F Pinsky, Timothy R Church, Grant Izmirlian, Barnett S Kramer. Cancer 2013
169
13

Predictive accuracy of the Liverpool Lung Project risk model for stratifying patients for computed tomography screening for lung cancer: a case-control and cohort validation study.
Olaide Y Raji, Stephen W Duffy, Olorunshola F Agbaje, Stuart G Baker, David C Christiani, Adrian Cassidy, John K Field. Ann Intern Med 2012
127
13


Cost-effectiveness of computed tomography screening for lung cancer in the United States.
Pamela M McMahon, Chung Yin Kong, Colleen Bouzan, Milton C Weinstein, Lauren E Cipriano, Angela C Tramontano, Bruce E Johnson, Jane C Weeks, G Scott Gazelle. J Thorac Oncol 2011
168
13

Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography.
Maurizio Infante, Silvio Cavuto, Fabio Romano Lutman, Eliseo Passera, Maurizio Chiarenza, Giuseppe Chiesa, Giorgio Brambilla, Enzo Angeli, Giuseppe Aranzulla, Arturo Chiti,[...]. Am J Respir Crit Care Med 2015
220
13

Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial.
Ugo Pastorino, Marta Rossi, Valentina Rosato, Alfonso Marchianò, Nicola Sverzellati, Carlo Morosi, Alessandra Fabbri, Carlotta Galeone, Eva Negri, Gabriella Sozzi,[...]. Eur J Cancer Prev 2012
300
13

Four-year results of low-dose CT screening and nodule management in the ITALUNG trial.
Andrea Lopes Pegna, Giulia Picozzi, Fabio Falaschi, Laura Carrozzi, Massimo Falchini, Francesca Maria Carozzi, Francesco Pistelli, Camilla Comin, Annalisa Deliperi, Michela Grazzini,[...]. J Thorac Oncol 2013
86
13

Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval.
Uraujh Yousaf-Khan, Carlijn van der Aalst, Pim A de Jong, Marjolein Heuvelmans, Ernst Scholten, Jan-Willem Lammers, Peter van Ooijen, Kristiaan Nackaerts, Carla Weenink, Harry Groen,[...]. Thorax 2017
158
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.